RU2013146452A - INJECTION OR INFUSION TRIAZAVIRINE SOLUTION FOR TREATING VIRAL INFECTIONS - Google Patents

INJECTION OR INFUSION TRIAZAVIRINE SOLUTION FOR TREATING VIRAL INFECTIONS Download PDF

Info

Publication number
RU2013146452A
RU2013146452A RU2013146452/15A RU2013146452A RU2013146452A RU 2013146452 A RU2013146452 A RU 2013146452A RU 2013146452/15 A RU2013146452/15 A RU 2013146452/15A RU 2013146452 A RU2013146452 A RU 2013146452A RU 2013146452 A RU2013146452 A RU 2013146452A
Authority
RU
Russia
Prior art keywords
injection
infusion
solution
triazavirine
viral infections
Prior art date
Application number
RU2013146452/15A
Other languages
Russian (ru)
Other versions
RU2574007C2 (en
Inventor
Олег Иванович Киселев
Олег Николаевич Чупахин
Владимир Леонидович Русинов
Валерий Николаевич Чарушин
Элла Германовна Деева
Евгений Нарциссович Уломский
Original Assignee
Олег Иванович Киселев
Олег Николаевич Чупахин
Владимир Леонидович Русинов
Валерий Николаевич Чарушин
Элла Германовна Деева
Евгений Нарциссович Уломский
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Иванович Киселев, Олег Николаевич Чупахин, Владимир Леонидович Русинов, Валерий Николаевич Чарушин, Элла Германовна Деева, Евгений Нарциссович Уломский filed Critical Олег Иванович Киселев
Priority to RU2013146452/15A priority Critical patent/RU2574007C2/en
Publication of RU2013146452A publication Critical patent/RU2013146452A/en
Application granted granted Critical
Publication of RU2574007C2 publication Critical patent/RU2574007C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Инъекционный или инфузионный раствор, содержащий биологически активное вещество и воду, отличающийся тем, что в качестве биологически активного вещества содержит триазавирин в количестве 0,05-4,0%, считая на общий вес раствора, в форме солей с основаниями или аминокислотами и пептидами или их смесей, воду до 100 вес. %.2. Инъекционный или инфузионный раствор по п. 1, отличающийся тем, что дополнительно содержит 0,1-30,0 вес. % вспомогательных веществ.1. Injection or infusion solution containing a biologically active substance and water, characterized in that as a biologically active substance contains triazavirin in an amount of 0.05-4.0%, based on the total weight of the solution, in the form of salts with bases or amino acids and peptides or mixtures thereof, water up to 100 weight. % .2. Injection or infusion solution according to claim 1, characterized in that it further comprises 0.1-30.0 weight. % excipients.

Claims (2)

1. Инъекционный или инфузионный раствор, содержащий биологически активное вещество и воду, отличающийся тем, что в качестве биологически активного вещества содержит триазавирин в количестве 0,05-4,0%, считая на общий вес раствора, в форме солей с основаниями или аминокислотами и пептидами или их смесей, воду до 100 вес. %.1. Injection or infusion solution containing a biologically active substance and water, characterized in that as a biologically active substance contains triazavirin in an amount of 0.05-4.0%, based on the total weight of the solution, in the form of salts with bases or amino acids and peptides or mixtures thereof, water up to 100 weight. % 2. Инъекционный или инфузионный раствор по п. 1, отличающийся тем, что дополнительно содержит 0,1-30,0 вес. % вспомогательных веществ. 2. Injection or infusion solution according to claim 1, characterized in that it further comprises 0.1-30.0 weight. % excipients.
RU2013146452/15A 2013-10-16 2013-10-16 Injection solution for treating viral diseases specified in h1n1, h3n2, h5n1 influenza, tick-borne encephalitis and west nile fever RU2574007C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013146452/15A RU2574007C2 (en) 2013-10-16 2013-10-16 Injection solution for treating viral diseases specified in h1n1, h3n2, h5n1 influenza, tick-borne encephalitis and west nile fever

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013146452/15A RU2574007C2 (en) 2013-10-16 2013-10-16 Injection solution for treating viral diseases specified in h1n1, h3n2, h5n1 influenza, tick-borne encephalitis and west nile fever

Publications (2)

Publication Number Publication Date
RU2013146452A true RU2013146452A (en) 2015-04-27
RU2574007C2 RU2574007C2 (en) 2016-01-27

Family

ID=53282921

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013146452/15A RU2574007C2 (en) 2013-10-16 2013-10-16 Injection solution for treating viral diseases specified in h1n1, h3n2, h5n1 influenza, tick-borne encephalitis and west nile fever

Country Status (1)

Country Link
RU (1) RU2574007C2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2703535C1 (en) * 2018-07-25 2019-10-21 Александр Александрович Петров Combination of antiviral agents for treating influenza viral pneumonia and use thereof
CN111388429A (en) * 2020-04-16 2020-07-10 宁夏蓝博思化学技术有限公司 Freeze-dried powder injection of broad-spectrum antiviral drug Triazavirin and preparation method thereof
CN114984030A (en) * 2022-06-23 2022-09-02 中国人民解放军海军军医大学 Application of ribavirin in preparation of tick-borne encephalitis virus resistant drugs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2721876C1 (en) * 2019-10-31 2020-05-25 Юрий Михайлович Амбалов Method for etiopathogenetic treatment of influenza patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500784A1 (en) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin solutions for injection or infusion
RU2294936C1 (en) * 2005-06-29 2007-03-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Уральский Государственный Технический Университет-УПИ 2-methylthio-6-nitro-1,2,4-triazolo[5,1-c]-1,2,4-triazine-7(4h)-one sodium salt dihydrate possessing antiviral activity
WO2011011519A1 (en) * 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
RU2012112128A (en) * 2012-03-29 2013-10-10 Холин Максим Николаевич PI3K / AKT / IKK / NF-kB SIGNAL PATH INHIBITORS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND THEIR COMPOSITIONS FOR PREVENTION AND TREATMENT OF VIRAL DISEASES

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2703535C1 (en) * 2018-07-25 2019-10-21 Александр Александрович Петров Combination of antiviral agents for treating influenza viral pneumonia and use thereof
CN111388429A (en) * 2020-04-16 2020-07-10 宁夏蓝博思化学技术有限公司 Freeze-dried powder injection of broad-spectrum antiviral drug Triazavirin and preparation method thereof
CN111388429B (en) * 2020-04-16 2022-03-15 宁夏蓝博思化学技术有限公司 Freeze-dried powder injection of broad-spectrum antiviral drug Triazavirin and preparation method thereof
CN114984030A (en) * 2022-06-23 2022-09-02 中国人民解放军海军军医大学 Application of ribavirin in preparation of tick-borne encephalitis virus resistant drugs

Also Published As

Publication number Publication date
RU2574007C2 (en) 2016-01-27

Similar Documents

Publication Publication Date Title
EA201892671A1 (en) PIGPED PORK INTERFERON AND METHODS OF ITS APPLICATION
CL2015003298A1 (en) Novel bridged heteroaryl dihydropyrimidines in 6 for the treatment and prophylaxis of hepatitis B virus infection
CL2016001405A1 (en) A peptide mixture
BR112018075140A2 (en) composition in the form of an injectable aqueous solution, and single dose formulation at a pH of 7 to 7.8
EA201890729A1 (en) ADJUSTABLE OPTIONS OF DOMAINS OF THE SUPERFAMINATION OF IMMUNOGLOBULINS AND THERAPY WITH CONSTRUCTED CELLS
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CL2015000942A1 (en) Compounds of substituted benzene.
EA201591004A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201590058A1 (en) ANALOGUE GLUACAGONA
EA201591702A1 (en) COMBINATION OF TWO ANTI-VIRAL PREPARATIONS FOR THE TREATMENT OF HEPATITIS C
CL2015002897A1 (en) Bace1 inhibitors
EA201592081A1 (en) CONNECTIONS ON THE BASIS OF MICRO-RNA AND METHODS FOR MODULATING ACTIVITY OF miR-122
CY1125033T1 (en) METHOTREXATE PREPARATION
EA201591752A1 (en) DIPEPTIDE AND TRIPEPTID EPOXYETONIC PROTEASE INHIBITORS
EA201501054A1 (en) TREATMENT OF MYOPATHIES AND NEURODEGENERATIVE DISEASES ASSOCIATED WITH THE PROTECTION OF PROTEINS BY PARENTAL INTRODUCTION OF TRAGOSE
RU2013146452A (en) INJECTION OR INFUSION TRIAZAVIRINE SOLUTION FOR TREATING VIRAL INFECTIONS
PH12017500450A1 (en) Flavivirus virus like particle
EA201590061A1 (en) PHARMACEUTICAL COMPOSITION
EA201590601A1 (en) APPLICATION OF PEDF-DERIVED POLYPEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS
EA201790223A1 (en) WATER PREPARATION CONTAINING PARACETAMOL AND IBUPROFEN
CO7030958A2 (en) Substituted benzylamine compounds, their use in medicine, and in particular in the treatment of hepatitis C virus infection (vch)
EA201690626A1 (en) NEW COMPOSITION OF HONADOTROPINS
MX2016007224A (en) Vaccine against porcine circo virus type 2.
EA201690966A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150617

HE9A Changing address for correspondence with an applicant
FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20150617

MM4A The patent is invalid due to non-payment of fees

Effective date: 20171017